Ralliant Corporation $RAL Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. trimmed its holdings in shares of Ralliant Corporation (NYSE:RAL) by 6.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 356,688 shares of the company’s stock after selling 24,700 shares during the period. JPMorgan Chase & Co.’s holdings in Ralliant were worth $15,598,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of RAL. Mirabella Financial Services LLP acquired a new stake in Ralliant in the third quarter worth about $1,080,000. FNY Investment Advisers LLC increased its stake in Ralliant by 705.5% during the 3rd quarter. FNY Investment Advisers LLC now owns 3,496 shares of the company’s stock valued at $152,000 after buying an additional 3,062 shares during the period. Hudson Bay Capital Management LP raised its position in shares of Ralliant by 278.8% during the 3rd quarter. Hudson Bay Capital Management LP now owns 179,891 shares of the company’s stock worth $7,867,000 after buying an additional 132,403 shares in the last quarter. Cantor Fitzgerald L. P. bought a new stake in shares of Ralliant during the 3rd quarter worth about $437,000. Finally, CIBC Bancorp USA Inc. acquired a new stake in shares of Ralliant in the 3rd quarter worth approximately $403,000.

Ralliant Stock Performance

Shares of RAL opened at $41.02 on Friday. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58. The firm’s 50 day moving average is $46.43 and its 200-day moving average is $46.68. Ralliant Corporation has a 12-month low of $37.27 and a 12-month high of $57.02. The stock has a market capitalization of $4.58 billion and a P/E ratio of 20.93.

Ralliant (NYSE:RAL) last released its earnings results on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, beating the consensus estimate of $0.67 by $0.02. The business had revenue of $554.60 million for the quarter, compared to analyst estimates of $543.04 million. Ralliant’s revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 23rd. Stockholders of record on Monday, March 9th were given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Monday, March 9th. Ralliant’s dividend payout ratio is 10.20%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Vertical Research upgraded shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price objective for the company in a report on Friday, February 6th. Weiss Ratings downgraded Ralliant from a “hold (c)” rating to a “sell (d)” rating in a research report on Thursday, February 5th. Oppenheimer decreased their price target on Ralliant from $60.00 to $50.00 and set an “outperform” rating for the company in a research note on Friday, February 6th. Royal Bank Of Canada lowered their price target on Ralliant from $52.00 to $41.00 and set a “sector perform” rating on the stock in a research report on Friday, February 6th. Finally, Citigroup dropped their price objective on Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a research note on Friday, February 6th. Seven equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, Ralliant has a consensus rating of “Hold” and an average target price of $50.50.

Insider Activity at Ralliant

In related news, SVP Amir A. Kazmi acquired 2,545 shares of Ralliant stock in a transaction dated Friday, February 6th. The stock was acquired at an average cost of $39.27 per share, with a total value of $99,942.15. Following the purchase, the senior vice president directly owned 39,699 shares in the company, valued at $1,558,979.73. The trade was a 6.85% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Karen M. Bick sold 2,530 shares of Ralliant stock in a transaction on Thursday, March 5th. The stock was sold at an average price of $46.50, for a total value of $117,645.00. Following the completion of the transaction, the senior vice president owned 42,652 shares in the company, valued at $1,983,318. The trade was a 5.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have acquired 8,145 shares of company stock worth $332,233.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.